Fig. 3

The ROC of the VAT area/FM with significant differences in all patients and in Group A, Group B and Group A & B, the ROC of the MFI with significant differences in all patients and Group A. The AUC of the VAT area/FM in all patients’ curve with 49.12% sensitivity and 85.96% specificity was 0.707 [95% CI 0.625–0.789]. Patients with a ratio higher than 0.578 tended to be recurrence within 1 year (A). The AUC of the MFI in all patients’ curve with 49.12% sensitivity and 85.09% specificity was 0.709 [95% CI 0.627–0.791]. Patients with a value higher than 1.394 tended to be recurrence within 1 year (B). The AUC of the VAT area/FM in Group A curve with 72.41% sensitivity and 54.28% specificity was 0.849 [95% CI 0.752–0.950]. Patients with a ratio higher than 0.442 tended to get recurrence within 1 year (C). The AUC of the MFI in Group B curve with 75.86% sensitivity and 82.14% specificity was 0.820 [95% CI 0.748–0.945]. Patients with a value higher than 1.319 tended to get recurrence within 1 year (D). The AUC of the VAT area/FM in Group B curve with 64.58% sensitivity and 77.27% specificity was 0.706 [95% CI 0.568–0.844]. Patients with a ratio higher than 0.491 tended to get recurrence within 1 year (E). The AUC of the VAT area/FM in Group A & B curve with 50.98% sensitivity and 89.47% specificity was 0.752 [95% CI 0.665–0.838]. Patients with a ratio higher than 0.578 tended to get recurrence within 1 year (F). Since there was no significant difference between VAT area/FM or MFI and whether recurrence within 1 year or not in other groups, the ROC curve was not drawn